Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087

CODEN : IJPPTK

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, more...


Article type

Review Article


Article page

189-194


Authors Details

Abhishek Sharma*, Gulnaz Bano, Abdul Malik


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 185

PDF Downloaded: 91


Mucormycosis: A manifestation in COVID-19 infection


Review Article

Author Details : Abhishek Sharma*, Gulnaz Bano, Abdul Malik

Volume : 8, Issue : 3, Year : 2021

Article Page : 189-194

https://doi.org/10.18231/j.ijpp.2021.032



Suggest article by email


Abstract

Patients with COVID-19 may develop higher susceptibility to fungal co-infections. Mucormycosis is a rare and often life-threatening disease caused by vascular invasion by hyphae, leading to thrombosis and necrosis. Mucormycosis has been the cause of morbidity and mortality in transplant, ICU and immunodeficient individuals over a long period of time, but in India, a rapid increase in the number of cases seen in unexpected patients with Covid-19, which is a major concern. Covid-19 patients, already immunocompromised with underlying condition, had been exposed to severe Covid-19 infection and been using steroids, were at greater risk of developing mucormycosis. Out of ten cases reported by Sir Ganga Ram Hospital, Delhi India in December2020, five succumbed to mucormycosis. Another unique feature reported in mucor patients was age, most were elderly with ages between 45 to 60 years. The mortality rate is currently estimated at 50% in India. Symptoms such as nasal congestion, swelling of the eye or cheeks and dark brown crusts inside the nose should be reported immediately and anti-fungal treatment should be started.


Keywords: COVID-19 infection, Immunocompromised host, Mucormycosis, Nasal congestion, Thrombosis


How to cite : Sharma A, Bano G, Malik A, Mucormycosis: A manifestation in COVID-19 infection. Indian J Pharm Pharmacol 2021;8(3):189-194

Copyright © 2021 by author(s) and Indian J Pharm Pharmacol. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (creativecommons.org)







Wiki in hindi